Advertisement
Cigna-Express Scripts deal unlikely to benefit consumers

Cigna-Express Scripts deal unlikely to benefit consumers

By Alex Kacik and Shelby Livingston  |  March 12, 2018

The $67 billion merger would allow Cigna to lower its costs by insourcing PBM services, and absorb the profits of the biggest stand-alone PBM at a time when its competitors are also pairing up with providers of pharmacy services.

Cigna to buy Express Scripts in $67 billion deal

Cigna to buy Express Scripts in $67 billion deal

By Shelby Livingston  |  March 08, 2018

Supply chain experts are skeptical the $67 billion Cigna Corp.-Express Scripts deal will do much to transform the healthcare industry, let alone deliver any significant savings to customers.

Express Scripts CFO Slusser to leave company

Express Scripts CFO Slusser to leave company

By Shelby Livingston  |  October 24, 2017

The nation's largest pharmacy benefit manager Express Scripts said its CFO Eric Slusser is leaving the company. James Havel, an executive vice president, is taking his place.

Express Scripts to acquire EviCore Healthcare for $3.6B

Express Scripts to acquire EviCore Healthcare for $3.6B

By Alex Kacik  |  October 10, 2017

Pharmacy benefit manger Express Scripts will acquire medical benefits management company EviCore Healthcare for $3.6 billion, a move that will allow the company to access that growing market, the company said Tuesday.

Express Scripts to limit opioids; doctors concerned

Express Scripts to limit opioids; doctors concerned

By Associated Press  |  August 17, 2017

The American Medical Association says doctors and their patients, not pharmacy benefit managers, should determine opioid treatment plans, criticizing Express Scripts' plan to limit the number and strength of opioid drugs prescribed to first-time users.

Editorial: Tax reform is going nowhere

Editorial: Tax reform is going nowhere

By Merrill Goozner  |  August 07, 2017

In a rational political environment, there's a strong argument for tax reform—the next item on President Donald Trump's agenda. But we don't live in such an environment. Cutting taxes when the economy is near full employment will do nothing more than blow a massive hole in the federal budget.

Express Scripts' profit grows despite dwindling revenue from Anthem

By Alex Kacik  |  July 26, 2017

The largest pharmacy benefit manager in the country will lose Anthem's business in 2019, which is a sizable chunk of its business. For now, it's riding increasing specialty drug claims and home delivery revenue to an 11% second-quarter profit increase.

Blink Health ends Express Scripts contract over insulin program

Blink Health ends Express Scripts contract over insulin program

By Alex Kacik  |  June 14, 2017

Blink Health and Express Scripts partnered with Eli Lilly to provide up to a 40% discount on the drugmaker's insulin. An Express Scripts spokesman said Blink ended the contract because it did not want an exclusive relationship with the PBM, a violation of their agreement.

Editorial: The phony war on high drug prices

Editorial: The phony war on high drug prices

By Merrill Goozner  |  April 27, 2017

Politics, like nature, abhors a vacuum. Witness how the pharmaceutical industry has succeeded in taking advantage of President Donald Trump's failure to do something—anything—about high drug prices.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print